menu search

ALBT / Avalon GloboCare says 2023 will be ‘pivotal year' as it executes new commercial strategy

Avalon GloboCare says 2023 will be ‘pivotal year' as it executes new commercial strategy
Avalon GloboCare Corp (NASDAQ:ALBT) has updated investors on its progress in implementing its new commercial strategy focused on laboratory acquisitions and diagnostics.  In a letter to shareholders, the company's CEO David Jin noted that the company intends to play a leading role in the innovation of diagnostic testing, utilizing proprietary technology to deliver precise, genetics-driven results. Read More
Posted: Jul 10 2023, 10:09
Author Name: Proactive Investors
Views: 112659

ALBT News  

Avalon GloboCare debuts KetoAir app on Apple App Store

By Proactive Investors
October 4, 2023

Avalon GloboCare debuts KetoAir app on Apple App Store

Avalon GloboCare Corp (NASDAQ:ALBT) has officially unveiled its KetoAir mobile application on the Apple App Store. Coupled with an AI nutritionist and more_horizontal

Avalon GloboCare shares spike on Laboratory Services MSO acquisitions

By Proactive Investors
September 13, 2023

Avalon GloboCare shares spike on Laboratory Services MSO acquisitions

Avalon GloboCare Corp (NASDAQ:ALBT) announced that its 40% owned clinical diagnostics and reference lab Laboratory Services MSO (LSM) has made two si more_horizontal

Avalon GloboCare shares surge as recent momentum continues

By Proactive Investors
September 5, 2023

Avalon GloboCare shares surge as recent momentum continues

Avalon GloboCare Corp (NASDAQ:ALBT) shares climbed 29% to $1.24 on Tuesday after the precision diagnostics and clinical laboratory services provider more_horizontal

Avalon GloboCare adds QTY Code patent to its portfolio

By Proactive Investors
September 5, 2023

Avalon GloboCare adds QTY Code patent to its portfolio

Avalon GloboCare Corp (NASDAQ:ALBT) has received a new patent to add to its portfolio. The Freehold, New Jersey-based company announced the United Sta more_horizontal

Avalon GloboCare investee LSM launches innovative lab test for tuberculosis

By Proactive Investors
August 30, 2023

Avalon GloboCare investee LSM launches innovative lab test for tuberculosis

Avalon GloboCare Corp (NASDAQ:ALBT) announced that its 40% owned Laboratory Services MSO, LLC (LSM) is now offering an in-house laboratory developed t more_horizontal

Avalon GloboCare investee buys Houston-based lab testing facility

By Proactive Investors
July 24, 2023

Avalon GloboCare investee buys Houston-based lab testing facility

Avalon GloboCare Corp (NASDAQ:ALBT) announced that Laboratory Services MSO, in which the company holds a 40% interest, has acquired DE Laboratory LLC. more_horizontal

Avalon GloboCare investee LSM inks lab testing deal with GeneX

By Proactive Investors
July 19, 2023

Avalon GloboCare investee LSM inks lab testing deal with GeneX

Avalon GloboCare Corp (NASDAQ:ALBT) announced that its 40% owned Laboratory Services MSO, LLC (LSM) has signed an exclusive master service agreement ( more_horizontal

Avalon GloboCare says 2023 will be ‘pivotal year' as it executes new commercial strategy

By Proactive Investors
July 10, 2023

Avalon GloboCare says 2023 will be ‘pivotal year' as it executes new commercial strategy

Avalon GloboCare Corp (NASDAQ:ALBT) has updated investors on its progress in implementing its new commercial strategy focused on laboratory acquisitio more_horizontal


Search within

Pages Search Results: